In Vivo Efficacy of HfO2–Yb2O3 Nanopowders against Surface Tumors
- 16 September 2026
- journal article
- research article
- Published by Springer Nature in BioNanoScience
- Vol. 16 (10) , 604
Abstract
No abstract availableKeywords
Funding Information
- Russian Science Foundation (25-22-00281)
This publication has 40 references indexed in Scilit:
- Recent Advances in Hafnium Oxide Nanomaterials: From Controlled Synthesis, Structure, and Surface Engineering to Biomedical ApplicationsRare Metals, 2026
- Engineering Hafnium Oxide‐Based Nanoplatforms for Precision RadiosensitizationAdvanced Healthcare Materials, 2026
- Biogenic Synthesis of Zirconium Oxide Nanoparticles Using Allium cepa Peel Extract: A Potential Investigation of an In Silico Approach Against Dengue VirusChemistrySelect, 2025
- A review of ZrO2 nanoparticles applications and recent advancementsCeramics International, 2023
- Emerging Multimodel Zirconia Nanosystems for High‐Performance Biomedical ApplicationsAdvanced NanoBiomed Research, 2021
- In Vivo Tumor Growth Inhibition and Antiangiogenic Effect of Cyclic NGR Peptide-Daunorubicin Conjugates Developed for Targeted Drug DeliveryPathology and Oncology Research, 2019
- Dual purpose hafnium oxide nanoparticles offer imaging Streptococcus mutans dental biofilm and fight it In vivo via a drug free approachBiomaterials, 2018
- Extrapolating In Vitro Results to Predict Human Toxicity2014
- Characteristics of complement activation in mice bearing Lewis lung carcinomas treated by photodynamic therapyCancer Letters, 2005
- Energy spectrum of quasiparticles for various pairing states in 2-D extended hubbard modelJournal of Physics and Chemistry of Solids, 1995